Additional European Equity News
ASML (ASML NA) - CFO says in H2 an improvement will be seen in the service business, and EUV tools out of warranty. Working with supply chain and customers to make sure tariffs impact are as limited as possible. Tariffs are still very uncertain. (Newswires)
AstraZeneca (AZN LN) - CARES Phase III clinical programme of anselamimab in light chain amyloidosis did not meet primary endpoint. Evaluation of results are ongoing. (Newswires)
Ceconomy (CEC GY) - 9M (EUR): Adj EBIT 258mln. Q3: Sales growth adj. for currency and portfolio effects +5%. Guidance: FY Adj. EBIT 375mln. (Newswires)
Sobi (SOBI SS) - Q2 (SEK): EBIT 1.01bln (exp. 1.02bln), Revenue 6.17bln (exp. 6.18bln). (Newswires)
Stellantis (STLAM IM/STLAP FP) - Discontinues hydrogen fuel cell technology development programme; in discussions for alternatives. Has no staffing impact at production sites. (Newswires)
TotalEnergies (TTE FP) - Q2 Trading Update: European Refining Market Market USD 35.3/t (prev. USD 29.4/t Q/Q). Integrated LNG results exp. to reflect better environment conditions Y/Y. Refining and Chemicals exp. to be in same range as 2024. (Newswires)
16 Jul 2025 - 07:10- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts